New Announcement from Cambridge Cognition View this email in your browser


01/09/22 

New RNS Announcement:

£2.2m neurodegenerative disease trial contract

Recent announcements:
Alzheimer’s Disease Validation for NeuroVocalix
Directorate Change



UK Headquarters 
Cambridge Cognition Ltd 
Tunbridge Court, Tunbridge Lane
Bottisham, Cambridge 
CB25 9TU
Tel +44 (0)1223 810700 
Email[email protected]
US Headquarters
Cambridge Cognition Ltd
Cambridge Innovation Center
One Broadway, Cambridge 
MA, 02142
Tel +1 (617) 859 6499
Email [email protected]

Forward this newsletter
Update subscription preferences